drugset
drugset / Trial / NCT02212938

Influence of a Standardised High Fat Breakfast on the Bioavailability of BI 14332 CL in Healthy Male Volunteers

NCT02212938 ↗

Phase 1 Completed 12 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the relative bioavailability of BI 14332 CL vs. BI 14332 CL after intake of a standardised high fat breakfast

Timeline

Start
2006-09
Primary completion
2006-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 14332 CL Unknown 10 mg —

Indications

No indication recorded.